SEARCH RESULTS FOR: ("cryptocurrency meaning in bengali馃挷itenthusiasts.com馃挷Cryptocurrency")(59449 results)
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Floseal Matrix is indicated in surgical procedures (other than in ophthalmic) as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.
BAXTER HEALTHCARE CORPORATION
1503350
In Commercial Distribution
- 50085412096105 ()
- 00085412096100 ()
- Total Volume: 5 Milliliter
1503350
- Collagen haemostatic agent, non-antimicrobial
Floseal Matrix is indicated in surgical procedures (other than in ophthalmic) as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.
BAXTER HEALTHCARE CORPORATION
1503349
In Commercial Distribution
- 00085412096094 ()
- Total Volume: 5 Milliliter
1503349
- Collagen haemostatic agent, non-antimicrobial
The Access AFP assay is a paramagnetic particle, chemiluminescent immunoassay for use with the Access Immunoassay Systems for the quantitative determination of alpha-fetoprotein (AFP) in:
1. Human serum, as an aid in the management of patients with non-seminomatous testicular cancer.
2. Maternal serum and amniotic fluid at 15 to 20 weeks gestation, to aid in the detection of fetal open neural tube defects (ONTD). Test results, when used in conjunction with ultrasonography, are safe and effective aids in the detection of fetal ONTD. The assay is intended for use in conjunction with other diagnostic tools such as ultrasound and amniography.
Beckman Coulter, Inc.
33211
In Commercial Distribution
- H628332111 ()
33211
- Trisomy 21-risk hormone IVD, kit, chemiluminescent immunoassay
LAP-BAND® Access Port Needle 3.5 inch Pouch
Reshape Lifesciences Inc.
B-20301-10
B-20301-10
- Subcutaneous infusion/injection port needle
LAP-BAND® Access Port Needle 2 inch Pouch
Reshape Lifesciences Inc.
B-20302-10
B-20302-10
- Subcutaneous infusion/injection port needle
TRUFILL n-BCA Liquid Embolic System Procedural Set Contents: (2) 1 g n-BCA, self-piercing caps, 1 g Ta Powder, 10 mL Ethiodized Oil, (3) 1 mL and (3) 3 mL syringes, 30 mL beaker, 18 G blunt fill needle, (2) 21 G hypodermic needles, syringe labels
Cerenovus, Inc.
632400NA
In Commercial Distribution
- 10886704085324 ()
632400NA
- Neurovascular embolization plug
TRUFILL n-BCA Liquid Embolic System Procedural Set Contents: 1 g n-BCA, self-piercing cap, 1 g Ta Powder, 10 mL Ethiodized Oil, (3) 1 mL and (3) 3 mL syringes, 30 mL beaker, 18 G blunt fill needle, (2) 21 G hypodermic needles, syringe labels
Cerenovus, Inc.
632500NA
In Commercial Distribution
- 10886704085317 ()
632500NA
- Neurovascular embolization plug
Contents:one 1 g tube n-BCA with self-piercing luer cap one 1 g vial Ta Powder one 10 mL vial Ethiodized Oil
Cerenovus, Inc.
631-500
In Commercial Distribution
- 10886704029151 ()
631500
- Neurovascular embolization plug
Contents:two 1 g tubes n-BCA with self-piercing luer cap one 1 g vial Ta Powder one 10 mL vial Ethiodized Oil
Cerenovus, Inc.
631-400
In Commercial Distribution
- 10886704029144 ()
631400
- Neurovascular embolization plug
The VisuMax laser keratome is a femtosecond laser. It generates a beam of ultra-short laser pulses which
are guided through the aperture in the treatment objective .
The optical system focuses the laser beam into the corneal tissue.
The VisuMax femtosecond laser is indicated for use in ophthalmic surgery for the creation of corneal incisions in patients undergoing the following treatments:
- In the creation of a corneal flap in patients undergoing LASIK surgery or other treatment requiring initial lamellar resection of the cornea
- In patients undergoing surgery or other treatment requiring initial lamellar resection of the cornea
- In the creation of a lamellar cut/resection of the cornea for lamellar keratoplasty
- In the creation of a cut/incision for penetrating keratoplasty and corneal harvesting
- Surgery or other treatment requiring initial lamellar resection of the cornea to create tunnels for placement of corneal ring segments.
Additionally under class III:
The VisuMax Femtosecond Laser is indicated for use in small incision
lenticule extraction (SMILE) for the reduction or elimination of
myopia with or without astigmatism
• for spherical refractive error (in minus cylinder format) from -1.00 diopters through -10.00 diopters,
• for cylinder from -0.75 diopters through -3.00 diopters,
• when refraction spherical equivalent is no greater in magnitude than 10.00 diopters,
in patients 22 years of age or older with documentation of stable manifest refraction over the past year as demonstrated by a change in sphere and cylinder of lower or equal 0.50 D in magnitude.
Carl Zeiss Meditec AG
VisuMax
In Commercial Distribution
- 04049471095036 ()
- Weight (basic unit) 470 kg
- Weight (PSS): 250 kg
- Weight (platform): 150 kg
- L x W: 4.00 m x 3.70 m
- Femtosecond ophthalmic solid-state laser system